会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Conotoxin peptides
    • 芋螺毒素肽
    • US5633347A
    • 1997-05-27
    • US480750
    • 1995-06-07
    • Baldomero M. OliveraLourdes J. CruzDavid R. HillyardJ. Michael McIntoshAmeurfino O. Santos
    • Baldomero M. OliveraLourdes J. CruzDavid R. HillyardJ. Michael McIntoshAmeurfino O. Santos
    • A61K38/00A61K39/00C07K14/435
    • C07K14/435C07K14/43504A61K38/00A61K39/00Y10S530/857
    • The invention is directed to A-lineage conotoxin peptides, which are conotoxin peptides that have strong homology in the signal sequence and the 3'-untranslated region of the genes coding for these peptides to the sequences in the .alpha.-conotoxin peptides. The A-lineage conotoxin peptides include the .alpha.-conotoxin peptides, the .alpha.-conotoxin-like peptides and the .kappa.-conotoxin peptides, described further below. The .alpha.-conotoxin-peptides generally share a "core" sequence motif. This core sequence is termed the .alpha.3/5 core and is represented as Cys-Cys-Xaa-Xaa-Xaa- Cys-Xaa-Xaa-Xaa-Xaa-Xaa-Cys (SEQ ID NO:1). The .alpha.-conotoxin-like peptides generally share a core sequence termed the .alpha.4/7 core and is represented as Cys-Cys-Xaa-Xaa-Xaa-Xaa-Cys-Xaa- Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Cys (SEQ ID NO:2). The .kappa.-conotoxin peptides generally have a core sequence termed the .kappa.7/2/1/3 core and is represented as Cys-Cys-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa- Xaa-Cys-Xaa-Xaa-Cys-Xaa-Cys-Xaa-Xaa-Xaa-Cys (SEQ ID NO:3).
    • 本发明涉及A系血凝素毒素肽,其是在编码这些肽的基因的信号序列和3'非翻译区与α-毒素肽序列中具有强同源性的芋螺毒素肽。 A系血凝素毒素肽包括下文进一步描述的α-毒素肽,α-毒素样肽和κ-毒素肽。 α-毒素 - 肽通常共有“核心”序列基序。 该核心序列称为α3/5核心,并表示为Cys-Cys-Xaa-Xaa-Xaa- Cys-Xaa-Xaa-Xaa-Xaa-Xaa-Cys(SEQ ID NO:1)。 α-类毒素样肽通常共有称为α4/7核心的核心序列,并表示为Cys-Cys-Xaa-Xaa-Xaa-Xaa-Cys-Xaa- Xaa-Xaa-Xaa-Xaa-Xaa-Xaa -Cys(SEQ ID NO:2)。 κ-毒素肽通常具有称为κ7/2/1/3核心的核心序列,并且表示为Cys-Cys-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa- Xaa-Cys-Xaa-Xaa-Cys -Xaa-Cys-Xaa-Xaa-Xaa-Cys(SEQ ID NO:3)。
    • 7. 发明授权
    • Conotoxin peptides
    • 芋螺毒素肽
    • US5595972A
    • 1997-01-21
    • US487174
    • 1995-06-07
    • Baldomero M. OliveraLourdes J. CruzDavid R. HillyardJ. Michael McIntoshAmeurfino D. Santos
    • Baldomero M. OliveraLourdes J. CruzDavid R. HillyardJ. Michael McIntoshAmeurfino D. Santos
    • A61K38/00A61K38/17A61K39/00A61K49/00A61P35/00C07K14/435A61K38/10
    • C07K14/435A61K38/17C07K14/43504A61K39/00Y10S436/813
    • The invention is directed to A-lineage conotoxin peptides, which are conotoxin peptides that have strong homology in the signal sequence and the 3'-untranslated region of the genes coding for these peptides to the sequences in the .alpha.-conotoxin peptides. The A-lineage conotoxin peptides include the .alpha.-conotoxin peptides, the .alpha.-conotoxin-like peptides and the .kappa.-conotoxin peptides, described further below. The .alpha.-conotoxin-peptides generally share a "core" sequence motif. This core sequence is termed the .alpha.3/5 core and is represented as Cys-Cys-Xaa-Xaa-Xaa-Cys-Xaa-Xaa-Xaa-Xaa-Xaa-Cys (SEQ ID NO: 1). The .alpha.-conotoxin-like peptides generally share a core sequence termed the .alpha.4/7 core and is represented as Cys-Cys-Xaa-Xaa-Xaa-Xaa-Cys-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Cys (SEQ ID NO:2). The .kappa.-conotoxin peptides generally have a core sequence termed the .kappa.7/2/1/3 core and is represented as Cys-Cys-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Cys-Xaa-Xaa-Cys-Xaa-Cys-Xaa-Xaa-Xaa-Cys (SEQ ID NO:3) .alpha.-conotoxins MII (SEQ ID NO:54) and U002 (SEQ ID NO:10) preferentially bind to neuronal nicotinic acetylcholine receptors, rather than neuromuscular receptors. These latter two conotoxins can be used to diagnose and treat small-cell lung carcinomas, which have cholinergic nicotinic receptors.
    • 本发明涉及A系血凝素毒素肽,其是在编码这些肽的基因的信号序列和3'非翻译区与α-毒素肽序列中具有强同源性的芋螺毒素肽。 A系血凝素毒素肽包括下文进一步描述的α-毒素肽,α-毒素样肽和κ-毒素肽。 α-毒素 - 肽通常共有“核心”序列基序。 该核心序列称为α3/ 5核,并表示为Cys-Cys-Xaa-Xaa-Xaa-Cys-Xaa-Xaa-Xaa-Xaa-Xaa-Cys(SEQ ID NO:1)。 α-类毒素样肽通常共有称为α4/7核心的核心序列,并表示为Cys-Cys-Xaa-Xaa-Xaa-Xaa-Cys-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa -Cys(SEQ ID NO:2)。 κ-毒素肽通常具有称为kappa 7/2/1/3核心的核心序列,并且表示为Cys-Cys-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Cys-Xaa-Xaa-Cys -Xaa-Cys-Xaa-Xaa-Xaa-Cys(SEQ ID NO:3)α-毒素MII(SEQ ID NO:54)和U002(SEQ ID NO:10)优先结合神经元烟碱乙酰胆碱受体,而不是神经肌肉 受体。 后两种芋螺毒素可用于诊断和治疗具有胆碱能烟碱受体的小细胞肺癌。
    • 9. 发明授权
    • Conotoxin peptides
    • 芋螺毒素肽
    • US5514774A
    • 1996-05-07
    • US137800
    • 1993-10-19
    • Baldomero M. OliveraLourdes J. CruzDavid R. HillyardJ. Michael McIntoshAmeurfina D. Santos
    • Baldomero M. OliveraLourdes J. CruzDavid R. HillyardJ. Michael McIntoshAmeurfina D. Santos
    • C12N15/09A61K38/00A61K39/00C07K7/06C07K7/08C07K14/435C12N15/12C07K7/00A61K38/04
    • C07K14/43504C07K14/435A61K38/00A61K39/00
    • The invention is directed to A-lineage conotoxin peptides, which are conotoxin peptides that have strong homology in the signal sequence and the 3'-untranslated region of the genes coding for these peptides to the sequences in the .alpha.-conotoxin peptides. The A-lineage conotoxin peptides include the .alpha.-conotoxin peptides, the .alpha.-conotoxin-like peptides and the .kappa.-conotoxin peptides, described further below. The .alpha.-conotoxin-peptides generally share a "core" sequence motif. This core sequence is termed the .alpha.3/5 core and is represented as Cys-Cys-Xaa-Xaa-Xaa-Cys-Xaa-Xaa-Xaa-Xaa-Xaa-Cys (SEQ ID NO:1). The .alpha.-conotoxin-like peptides generally share a core sequence termed the .alpha.4/7 core and is represented as Cys-Cys-Xaa-Xaa-Xaa-Xaa-Cys-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Cys (SEQ ID NO:2). The .kappa.-conotoxin peptides generally have a core sequence termed the .kappa.7/2/1/3 core and is represented as Cys-Cys-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Cys-Xaa-Xaa-Cys-Xaa-Cys-Xaa-Xaa-Xaa-Cys (SEQ ID NO:3).
    • 本发明涉及A系血凝素毒素肽,其是在编码这些肽的基因的信号序列和3'非翻译区与α-毒素肽序列中具有强同源性的芋螺毒素肽。 A系血凝素毒素肽包括下文进一步描述的α-毒素肽,α-毒素样肽和κ-毒素肽。 α-毒素 - 肽通常共有“核心”序列基序。 该核心序列称为α3/ 5核,并表示为Cys-Cys-Xaa-Xaa-Xaa-Cys-Xaa-Xaa-Xaa-Xaa-Xaa-Cys(SEQ ID NO:1)。 α-类毒素样肽通常共有称为α4/7核心的核心序列,并表示为Cys-Cys-Xaa-Xaa-Xaa-Xaa-Cys-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa -Cys(SEQ ID NO:2)。 κ-毒素肽通常具有称为kappa 7/2/1/3核心的核心序列,并且表示为Cys-Cys-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Xaa-Cys-Xaa-Xaa-Cys -Xaa-Cys-Xaa-Xaa-Xaa-Cys(SEQ ID NO:3)。
    • 10. 发明授权
    • Uses of &agr;-conotoxin peptides
    • α-芋螺毒素肽的使用
    • US06265541B1
    • 2001-07-24
    • US09219446
    • 1998-12-23
    • Baldomero M. OliveraJ. Michael McIntoshDoju YoshikamiG. Edward CartierSiqin Luo
    • Baldomero M. OliveraJ. Michael McIntoshDoju YoshikamiG. Edward CartierSiqin Luo
    • C07K1400
    • A61K38/17A61K38/08C07K14/43504
    • The present invention relates to the use of &agr;-conotoxin peptides having the general formula Xaa1-Xaa2-Cys-Cys-Xaa3-Xaa4-Pro-Xaa5-Cys-Xaa6-Cys (SEQ ID NO: 1) for treating disorders regulated at neuronal nicotinic acetylcholine receptors. Such disorders include, but are not limited to, cardiovascular disorders, gastric motility disorders, urinary incontinence, nicotine addiction, mood disorders (such as bipolar disorder, unipolar depression, dysthymia and seasonal effective disorder) and small cell lung carcinoma, as well as the localization of small cell lung carcinoma. In this formula, Xaa1 is des-Xaa1, Tyr, mono-iodo-Tyr or di-iodo-Tyr, Xaa2 is any amino acid, Xaa3 is any amino acid, Xaa4 is any amino acid, Xaa5 is any amino acid and Xaa6 represents a peptide of 3-7 amino acids. Disulfide linkages exist between the first and third cysteines and the second and fourth cysteines. Pro may be replaced with hydroxy-Pro. The C-terminus may contain a hydroxyl or an amide group, preferably an amide group.
    • 本发明涉及具有用于治疗在神经元烟碱乙酰胆碱受体调节的病症的通式的α-芋螺毒素肽的用途。 这些病症包括但不限于心血管疾病,胃动力障碍,尿失禁,尼古丁成瘾,情绪障碍(例如双相情感障碍,单极抑郁,精神抑郁和季节性有效障碍)和小细胞肺癌,以及 小细胞肺癌的定位。 在该式中,Xaa1是des-Xaa1,Tyr,单碘-Tyr或二碘-Tyr,Xaa2是任何氨基酸,Xaa3是任何氨基酸,Xaa4是任何氨基酸,Xaa5是任何氨基酸,Xaa6表示 3-7个氨基酸的肽。 第一和第三半胱氨酸与第二和第四半胱氨酸之间存在二硫键。 Pro可以用羟基替代。 C末端可以含有羟基或酰胺基,优选酰胺基。